A Long-Term Comparison of Galantamine and Donepezil in the Treatment of Alzheimer’s Disease

被引：0

作者：

Gordon Wilcock

Ian Howe

Hilary Coles

Sean Lilienfeld

Luc Truyen

Young Zhu

Roger Bullock

Paul Kershaw

机构：

[1] University of Bristol,Department of Care of the Elderly

[2] Frenchay Hospital,Department of Old Age Psychiatry, Kingshill Research Centre

[3] Shire Pharmaceuticals,undefined

[4] Ltd.,undefined

[5] Chineham,undefined

[6] Janssen-Cilag UK,undefined

[7] Saunderton,undefined

[8] Janssen Pharmaceutica Products,undefined

[9] L.P.,undefined

[10] Johnson & Johnson Pharmaceutical Research & Development,undefined

[11] LLC,undefined

[12] Victoria Hospital,undefined

来源：

Drugs & Aging | 2003年 / 20卷

关键词：

MMSE Score; Galantamine; Caregiver Burden; Neuronal Nicotinic Receptor; Baseline MMSE Score;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：777 / 789

页数：12

共 50 条

[1] A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease
Wilcock, G
Howe, I
Coles, H
Lilienfeld, S
Truyen, L
Zhu, Y
Bullock, R
[J]. DRUGS & AGING, 2003, 20 (10) : 777 - 789
[2] A long-term comparison of galantamine and donepezil in the treatment of moderate-to-severe Alzheimer's disease: A responder analysis
Bullock, R
Mahableshwarkar, AR
Lilienfeld, S
[J]. INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 250 - 251
[3] A long-term comparison of galantamine and donepezil in the treatment of moderate-to-severe Alzheimer's disease: An intent-to-treat analysis
Wilcock, G
Hammond, G
Lilienfeld, S
[J]. INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 240 - 241
[4] Long-term donepezil treatment in patients with Alzheimer’s disease
Andrew Kertesz
[J]. Current Neurology and Neuroscience Reports, 2004, 4 (6) : 459 - 460
[5] Long-term treatment with galantamine in patients with Alzheimer's disease and Alzheimer's disease with cerebrovascular disease
Feldman, H
Van Baelen, B
Brashear, HR
Schwalen, S
Kavanagh, S
[J]. NEUROBIOLOGY OF AGING, 2004, 25 : S198 - S199
[6] Galantamine vs Donepezil in the Treatment of Alzheimer’s Disease
Barry Goldlist
Michael Gordon
Gary Naglie
[J]. Drugs & Aging, 2003, 20 : 1139 - 1140
[7] Galantamine vs donepezil in the treatment of Alzheimer's disease
Goldlist, B
Gordon, M
Naglie, G
[J]. DRUGS & AGING, 2003, 20 (15) : 1139 - 1140
[8] Donepezil in the treatment of Alzheimer's disease - Long-term efficacy and safety
Rocca, P
Cocuzza, E
Marchiaro, L
Bogetto, F
[J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (02): : 369 - 373
[9] Alzheimer's disease - A long-term study with Donepezil
Diener, HC
[J]. PSYCHOPHARMAKOTHERAPIE, 1999, 6 (02): : 75 - 76
[10] Long-term cognitive benefits of galantamine treatment in patients with Alzheimer's disease
Wessel, T
Gaens, E
[J]. ANNALS OF NEUROLOGY, 2000, 48 (03) : 461 - 461

← 1 2 3 4 5 →